pSivida Announces New Board Appointments

Posted on: Monday, 14 July 2008, 09:01 CDT pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PSI), a leading drug delivery company headquartered in Watertown, MA, today announced the appointment to their Board of Directors of Peter G. Savas and Paul A. Hopper as non-executive Directors. Peter Savas is the Chairman and Chief Executive Officer of Alseres Pharmaceuticals, Inc. a NASDAQ listed (ALSE) biotechnology company based in Hopkinton, MA. engaged in the clinical development of biopharmaceutical products for the diagnosis of degenerative neurological diseases and the treatment of acute spinal cord injury. Mr. Savas has served as Chairman and CEO of Alseres since September 2004. Prior to joining Alseres, Mr. Savas was Chairman, President, and Chief Executive Officer of Aderis Pharmaceuticals which was subsequently sold to one of its... [read full story]